Interestingly, copy-number gains of the BRAF gene have been proposed as an alternative mechanism of activation in both melanoma and glioma [15, 16], as well as being a cause of resistance towards BRAF inhibitor treatment of advanced melanoma [17]. The gene discussed is BRAF; the disease is melanoma.